Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
SELECT: Preoperative Erlotinib in Early Stage NSCLC
NCT00462995Phase 2Completed
- Sponsor
- University Health Network
- Start
- May 2006
- Primary completion
- Jan 2012
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of erlotinib in non-small cell lung cancer (NSCLC), sponsored by University Health Network. Started May 2006; status: completed.
02
Drugs
erlotinib
03
Conditions
non-small cell lung cancer (NSCLC)
Beyond the preview
Go deeper on NCT00462995.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00462995.